ciclopirox has been researched along with SYC-435 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, L; Dong, S; Gallo, JM; Kogiso, M; Li, XN; Liu, Z; Lv, H; Qiu, JJ; Song, Y; Yao, Y; Zheng, B | 1 |
| Bao, F; Chen, X; Ding, X; Feng, H; Hu, J; Hu, L; Li, J; Li, X; Mao, F; Tang, Y; Wang, M; Wang, W; Wu, Z; Xu, Y; Yu, S; Zhang, H; Zhao, Q | 1 |
| Campbell, SD; Casals, AG; Donald, KA; Franson, AD; Griggs, DW; Marker, EM; Meyers, MJ; Morrison, LA; Mottaleb, MA; Narayana Hajay Kumar, TV; Raghava Reddy, LV; Reddy, MS; Sadhukhan, SK; Woodson, ME; Yu, AJ; Zangi, M | 1 |
3 other study(ies) available for ciclopirox and SYC-435
| Article | Year |
|---|---|
Inhibition of cancer-associated mutant isocitrate dehydrogenases: synthesis, structure-activity relationship, and selective antitumor activity.
Topics: Animals; Antineoplastic Agents; Blood-Brain Barrier; Brain Neoplasms; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Glioma; Glutarates; Humans; Isocitrate Dehydrogenase; Mice; Pyridones; Structure-Activity Relationship; Xenograft Model Antitumor Assays | 2014 |
Development of Novel
Topics: Animals; Antioxidants; Apoptosis; Brain; Cell Line, Tumor; Ciclopirox; Drug Design; Humans; Infarction, Middle Cerebral Artery; Male; Molecular Structure; Neuroprotective Agents; Rats, Sprague-Dawley; Structure-Activity Relationship | 2020 |
Synthetic derivatives of the antifungal drug ciclopirox are active against herpes simplex virus 2.
Topics: Acyclovir; Antifungal Agents; Antiviral Agents; Ciclopirox; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Virus Replication | 2022 |